IM Therapeutics Reports Positive Results of Phase 1b Trial of Lead Drug IMT-002
21 Jul 2021 //
BUSINESSWIRE
IM Therapeutics` lead diabetes candidate posts positive results
21 Jul 2021 //
FIERCEBIOTECH
IM Co-Founder Peter Gottlieb, M.D, to Present Advances in Genetically
26 Jun 2021 //
BUSINESSWIRE
IM Therapeutics Expands Management Team with David Alleva
06 Apr 2021 //
BUSINESSWIRE